Two premier oncology professional organizations, ESMO (European Society for Medical Oncology) and IASLC (International Association for the Study of Lung Cancer), held meetings in September.  On Thursday, October 7, at 8 pm Eastern Time (5 pm Pacific), #LCSM Chat will discuss major lung cancer findings from IASLC 2021 World Conference on Lung Cancer (#WCLC21) and the ESMO 2021 Annual Meeting (#ESMO21). We will examine #WCLC21 and #ESMO21 presentations that could have major impacts on lung cancer clinical care, and why these are important to the lung cancer community. Our moderator Charu Aggarwal (@CharuAggarwalMD) will lead our discussion using the following topics:

• T1: What new targeted therapy options were presented at #WCLC21 and #ESMO21?
• T2: What key biomarker and liquid biopsy presentations happened at #WCLC21 and #ESMO21?
• T3: What new ideas did #WCLC21 and #ESMO21 offer regarding adjuvant immunotherapy?
• T4: What did #WCLC21 and #ESMO21 presentations suggest about using immunotherapy when brain metastases are present?
• T5: What other #WCLC21 and #ESMO21 presentations or ideas captured you interest?

Please join us, and bring your experiences and wisdom! Remember to include #LCSM in ALL your tweets so the other chat participants can see them. You can read a primer on participating in the chat here. We look forward to chatting with you!